Jump to content

Verily

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Richcitii (talk | contribs) at 15:54, 3 August 2020 (added links to page). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Verily Life Sciences, LLC.
FormerlyGoogle Life Sciences
Company typeSubsidiary
Industry
FoundedDecember 7, 2015; 8 years ago (2015-12-07)
Key people
Andrew Conrad (CEO)
OwnerGoogle Inc. (until 2015)
Alphabet Inc. (2015–present)
ParentAlphabet Inc.
SubsidiariesLift Labs
Websiteverily.com

Verily Life Sciences, also known as Verily (formerly Google Life Sciences[1][2]), is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc.[3] This restructuring process was completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily.[4][5]

Researchers

As of July 2014, members of the research team include Andrew Conrad, founder of LabCorp's National Genetics Institute; Vik Bajaj, an expert in nuclear magnetic resonance; Marija Pavlovic, who studies the effect of radiation on DNA; Alberto Vitari, a cancer biologist; Brian Otis, who worked on Google Venture's glucose-sensing contact lens;[6] and Mark DePristo, who worked on the Genome Analysis Toolkit (GATK) at the Broad Institute.[7] Dr. Thomas R. Insel announced on September 15, 2015 that he was resigning as the director of the National Institute of Mental Health (NIMH) to join this division.[1]

Acquisitions and funding

On 9 September 2014, the division acquired Lift Labs, the makers of Liftware.[8]

Verily Life Sciences in January 2019 raised $1 billion in funding. Andy Conrad remained CEO.[9]

At the end of 2019, Verily sold its stake in robot-assisted surgery joint venture Verb Surgical to development partner Johnson & Johnson for an undisclosed sum.[10]

Projects

  • Develop comprehensive solutions that combine devices, software, medicine, and professional care to enable simple and intelligent disease management for people with diabetes, in partnership with Sanofi.[11]
  • A spoon for people with tremors.[12]
  • The Baseline Study, a project to collect genetic, molecular, and wearable device information from enough people to create a picture of what a healthy human should be.[13]
  • A health-tracking wristband.[14]
  • A disease-detecting nanoparticle platform[15] working with the wristband, a project called Tricorder.[16]
  • Advancements in surgical robotics, in partnership with Johnson & Johnson.[17]
  • Development and commercialization of bioelectronic medicines, in partnership with GlaxoSmithKline[18]
  • Development of miniaturized continuous glucose monitors (CGM) in partnership with Dexcom[19]
  • Contact lenses that allow people with diabetes to continually check their glucose levels using a non-intrusive method.[20] On November 16, 2018, Verily announced it discontinued this project.[21]
  • Smart shoes for health tracking and fall detection[22]

See also

References

  1. ^ a b "Archived copy". Archived from the original on September 18, 2015. Retrieved September 15, 2015.{{cite web}}: CS1 maint: archived copy as title (link)
  2. ^ Carey, Benedict. "Head of Mental Health Institute Leaving for Google Life Sciences". New York Times.
  3. ^ Brin, Sergey. "Google+ Post".
  4. ^ "Google Life Sciences debuts a new name, Verily". STAT. Retrieved 2015-12-07.
  5. ^ "Introducing Verily". YouTube. December 7, 2015. Retrieved December 24, 2017.
  6. ^ Barr, Alistair (Jul 25, 2014). "Meet the Google X Life Sciences Team". blogs.wsj.com. Retrieved 13 September 2014.
  7. ^ "Mark DePristo LinkedIn Profile". LinkedIn.
  8. ^ Chowdhry, Amit (10 September 2014). "Google Continues To Build Upon Its Life Sciences Ecosystem". forbes.com. Retrieved 13 September 2014.
  9. ^ Ron Leuty (January 3, 2019). "Google life sciences spinout Verily lines up $1B investment". Silicon Valley Business Journals. Retrieved January 5, 2019.
  10. ^ Hale, Conor (December 20, 2019). "Johnson & Johnson to take over Verb Surgical, its robotics venture with Verily". FierceBiotech.com. Archived from the original on January 8, 2020. Retrieved January 7, 2020.
  11. ^ "Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform - Sep 12, 2016". news.sanofi.us. Retrieved 2018-08-16.
  12. ^ Rushe, Dominic (2014-11-25). "Google launches 'smart' spoon to help steady shaking hands". The Guardian. Retrieved 25 November 2014.
  13. ^ Kaiser, Jocelyn (28 July 2014). "Google X sets out to define healthy human | Science/AAAS | News". news.sciencemag.org. Retrieved 13 September 2014.
  14. ^ Chen, Caroline (23 June 2015). "Google Reveals Health-Tracking Wristband". Bloomberg. Retrieved 24 June 2015.
  15. ^ Gibbs, Samuel (29 October 2014). "Google is developing a cancer and heart attack-detecting pill". The Guardian. Retrieved 20 January 2015.
  16. ^ "'Silicon Valley arrogance'? Google misfires as it strives to turn Star Trek technology into reality". 6 June 2016.
  17. ^ Ackerman, Evan (3 March 2016). "Google and Johnson & Johnson Conjugate to Create Verb Surgical, Promise Fancy Medical Robots". IEEE Spectrum. Retrieved 3 March 2016.
  18. ^ Pandey, Avaneesh (1 August 2016). "GlaxoSmithKline (GSK) Teams Up With Alphabet (GOOGL) Subsidiary Verily To Make Bioelectronic Medicines". International Business Times. Retrieved 1 August 2016.
  19. ^ "Verily Life Sciences". verily.com. Retrieved 2017-02-15.
  20. ^ Brian Otis; Babak Parviz (2014-01-16). "Introducing our smart contact lens project". Google. Retrieved 2014-01-17.
  21. ^ Brian Otis (16 November 2018). "Update on our Smart Lens program with Alcon". Verily Blog. Retrieved 21 November 2018.
  22. ^ Li, Abner (1 February 2019). "Verily developing smart shoes for health and weight tracking, fall detection". 9to5Google. Retrieved 1 February 2019.